Results 221 to 230 of about 208,828 (307)
Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees
EMBO Reports, 2011 Astrid Spannhoff, Yong Kee Kim, N. J. Raynal, Vazganush Gharibyan, M. Su, Yue Zhou, Jia Li, S. Castellano, G. Sbardella, J. Issa, M. Bedford +10 moresemanticscholar +1 more sourceEZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor. [PDF]
CellsSprinzen L, Garcia F, Mela A, Lei L, Upadhyayula P, Mahajan A, Humala N, Manier L, Caprioli R, Quiñones-Hinojosa A, Casaccia P, Canoll P. +11 moreeuropepmc +1 more sourceSupplemental Table S2 from The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, William J.E. Frye, José M. González Dalmasy, Li Wang, Drake A. Russell, Lyn M. Huff, Andrew J. Perciaccante, Fatima Ali-Rahmani, Crystal C. Lipsey, Heidi M. Wade, Allison V. Mitchell, Siddhardha S. Maligireddy, David Terrero, Donna Butcher, Elijah F. Edmondson, Lisa M. Jenkins, Tatiana Nikitina, Victor B. Zhurkin, Amit K. Tiwari, Anthony D. Piscopio, Rheem A. Totah, Susan E. Bates, H. Efsun Arda, Michael M. Gottesman, Pedro J. Batista +26 moreopenalex +1 more sourceAdenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects. [PDF]
Gastro Hep AdvKaldjob-Heinrich L, Nuciforo S, Lemke S, Stahl A, Czemmel S, Babaei S, Blukacz L, Meier MA, Zhang Y, Schürch CM, Gonzalez-Menendez I, Woelffing P, Malek NP, Scheble V, Nahnsen S, Claassen M, Templin M, Bösmüller H, Heim MH, Dauch D, Bitzer M. +20 moreeuropepmc +1 more sourceDeciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia.
Blood, 2011 M. Bishton, Simon J. Harrison, Simon J. Harrison, B. Martin, N. McLaughlin, C. James, E. Josefsson, Katya J. Henley, B. Kile, B. Kile, H. Prince, H. Prince, R. Johnstone +12 moresemanticscholar +1 more sourceMolecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor. [PDF]
Clin Transl MedShi ZY, Fang Y, Xu PP, Yi HM, Li JF, Dong Y, Zhu Y, Liu MK, Fu D, Wang S, Shi Q, Shen R, Zhong HJ, Wang CF, Cheng S, Wang L, Liu F, Zhao WL. +17 moreeuropepmc +1 more source